Edgewise Therapeutics, Inc. Common Stock
EWTX
$39.65
-0.25%
EWTX
Edgewise Therapeutics, Inc. Common Stock
$39.65
Related headlines
EWTX price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Edgewise Therapeutics, Inc. Common Stock's 12-month outlook, with a consensus price target around $52.62 and implied upside of +32.7% versus the current price.
Average Target
$52.62
0 analysts
Implied Upside
+32.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$36 - $66
Analyst target range
EWTX Technical Analysis
Beta
0.35
0.35x market volatility
Max Drawdown
-25.0%
Largest decline past year
52-Week Range
$15-$49
Price range past year
Annual Return
+155.6%
Cumulative gain past year
| Period | EWTX Return | S&P 500 |
|---|---|---|
| 1m | -11.2% | -0.1% |
| 3m | +0.9% | +4.7% |
| 6m | +25.6% | +8.3% |
| 1y | +155.6% | +15.2% |
| ytd | +66.9% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EWTX Fundamental Analysis
Quarterly Revenue
$0.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-159619000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EWTX Overvalued?
PE
-15.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-15.1x
Enterprise Value Multiple